Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.

Leavy OC. et al, (2024), ERJ Open Res, 10

Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study.

Samat AHA. et al, (2024), Int J Cardiol, 415

Differentiating Left Ventricular Remodeling in Aortic Stenosis From Systemic Hypertension.

Mahmod M. et al, (2024), Circ Cardiovasc Imaging, 17

CTEPH is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies.

Reddy SA. et al, (2024), Eur Respir J

Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study.

Siontis KC. et al, (2024), Eur Heart J Digit Health, 5, 416 - 426

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.

Coleman JA. et al, (2024), Cardiovascular research, cvae086 - cvae086

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy.

Coleman JA. et al, (2024), Frontiers in pharmacology, 15, 1379236 - 1379236

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.

Liew F. et al, (2024), Nat Immunol, 25, 607 - 621

Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.

Devine K. et al, (2024), Clin Endocrinol (Oxf), 100, 317 - 327

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.

Taquet M. et al, (2024), Brain Commun, 6

Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review.

Singh SJ. et al, (2023), Eur Respir Rev, 32

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy

Coleman J. et al, (2023), Computers in Biology and Medicine

Synbiotics in post-acute COVID-19 syndrome-a potential new treatment framework?

Raman B. and Ramasamy MN., (2023), Lancet Infect Dis

Long COVID research: an update from the PHOSP-COVID Scientific Summit.

Brightling CE. et al, (2023), Lancet Respir Med, 11, e93 - e94

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.

C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019

Personalizing Apical Hypertrophic Cardiomyopathy Diagnosis: A Major Step Forward, but Challenges Remain.

Raman B., (2023), JACC Cardiovasc Imaging

Erratum for: Lung Abnormalities Detected with Hyperpolarized 129Xe MRI in Patients with Long COVID.

Grist JT. et al, (2023), Radiology, 309

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.

Taquet M. et al, (2023), Nat Med

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.

Farrant J. et al, (2023), Heart, 109, 1175 - 1182

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy.

Coleman JA. et al, (2023), International Journal of Cardiovascular Imaging, 1 - 18

Load More

Include forthcoming?